Marino Brunori
Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari(IT)Azienda Sanitaria Locale di Asti(IT)Ospedale Santa Maria(IT)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, Cancer Treatment and Pharmacology, Cancer therapeutics and mechanisms
Most-Cited Works
- Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II study.(2006)
- → Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells(1998)70 cited
- → Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA(2012)62 cited
- → Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study(2013)61 cited
- → Amifostine can reduce mucosal damage after high‐dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective study(2000)58 cited
- → Common and rare side‐effects of low‐dose thalidomide in multiple myeloma: focus on the dose‐minimizing peripheral neuropathy(2004)51 cited